1Yim HJ,Lok AS.Natural history of chronic hepatitis B virus infection:what we knew in 1981 and what we know in 2005.Hepatology,2006,43(2 Suppl 1):S173-181.
2Hui CK,Bowden S,Jackson K,et al.Clinical significance of intrahepatic hepatitis B virus covalently closed circular DNA in chronic hepatitis B patients who received cytotoxic chemotherapy.Blood,2005,105(6):2616-2617.
3Yeo W,Johnson PJ.Diagnosis,prevention and management of hepatitis B virus reactivation during anticancer therapy.Hepatology,2006,43(2):209-220.
4Lalazar G,Rund D,Shouval D.Screening,prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies.Br J Haematol,2007,136(5):699-712.
5Lau GK.Hepatitis B reactivation after chemotherapy:two decades of clinical research.Hepatol Int,2008,2(2):152-162.
6Kusumoto S,Tanaka Y,Mizokami M,et al.Reactivation of hepatitis B virus following systemic chemotherapy for malignant lymphoma.Int J Hematol,2009,90(1):13-23.
8Liang R.How I treat and monitor viral hepatitis B infection in patients receiving intensive immunosuppressive therapies or undergoing hematopoietic stem cell transplantation.Blood,2009,113(14):3147-3153.
9Lau GK,Leung YH,Fong DY,et al.High hepatitis B virus(HBV) DNA viral load as the most important risk factor for HBV reactivation in patients positive for HBV surface antigen undergoing autologous hematopoietic cell transplantation.Blood,2002,99(7):2324-2330.
10Zhong S,Yeo W,Schroder C,et al.High hepatitis B virus(HBV) DNA viral load is an important risk factor for HBV reactivation in breast cancer patients undergoing cytotoxic chemotherapy.J Viral Hepat,2004,11(1):55-59.
8Shiota G, Harada K, Oyama K,et al. Severe exacerbation of hepatitis af- ter short-term corticosteroid therapy in a patients with "latent" chronic hep- atitis B[J]. Liver, 2000,20 (5) : 415-420.
10Cheng AL, Hsiung CA, Su I J, et al. Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lympho mar.ll. Heoatoloav .2003.37(6) : 1320-1328.
